Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The US drug regulator is accused of misrepresenting data on COVID-19 therapies. A decade ago, it set criteria to ensure its decisions are driven by science.